Merck's Q2 Sales Got Clobbered by COVID-19, but Still Beat Estimates

Merck's Q2 Sales Got Clobbered by COVID-19, but Still Beat Estimates

Solid performances by the big drugmaker's cancer drugs helped offset headwinds from the pandemic.